Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 4/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 2/20 | 0.33 |
| ▸ | HTR1A | P08908 | 2/20 | 0.32 |
| ▸ | HTR7 | P34969 | 2/20 | 0.32 |
| ▸ | HTR6 | P50406 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 4/20 | 0.32 |
| ▸ | CA2 | P00918 | 4/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20754181 | 0.91 | AHR (0.39) | AHRCNR2MAOACA1CA2 | |
| SCHEMBL22760633 | 0.87 | AHR (0.43) | AHRCNR2MAOAHTR1AHTR7 | |
| SCHEMBL23913394 | 0.85 | AHR (0.40) | AHRCNR2CA1CA2 | |
| SCHEMBL20754299 | 0.82 | AHR (0.37) | AHRCNR2MAOACA1CA2 | |
| SCHEMBL22924205 | 0.81 | CA1 (0.39) | AHRCNR2MAOACA1CA2 | |
| SCHEMBL9576647 | 0.77 | MAOA (0.52) | MAOA | |
| SCHEMBL25185698 | 0.76 | AHR (0.36) | AHRMAOACA1CA2 | |
| SCHEMBL21455970 | 0.75 | AHR (0.33) | AHRCNR2MAOACA1CA2 | |
| SCHEMBL25185349 | 0.72 | CDC14B (0.33) | AHRCNR2MAOACA1CA2 | |
| SCHEMBL20982346 | 0.72 | CA1 (0.33) | CNR2CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210320260-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2021-10-14 | — | — | US | disclosed |
| US-20190058131-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2019-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210320260-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | CRY1, CYP1A1, TRPC1 | AHR 69/4885CNR2 446/4885MAOA 939/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.